Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of Squamous Cell Carcinoma antigen2 in Verruca Vulgaris

NCT05409365 is registered in ClinicalTrials.gov with Sohag University as lead sponsor.

NCT NCT05409365
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05409365 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of Squamous Cell Carcinoma antigen2 in Verruca Vulgaris
Lead sponsor
Sohag University
Phase
Observational
Overall status
Unknown status
Start date
May 1, 2022
Completion date
January 1, 2023
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy, verruca vulgaris